Open Access

[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice

  • Authors:
    • Sitelbanat Yassin
    • Jialiang Hu
    • Hanmei Xu
    • Ce Li
    • Sarra Setrerrahmane
  • View Affiliations

  • Published online on: February 13, 2020     https://doi.org/10.3892/or.2020.7503
  • Pages: 1349-1349
  • Copyright : © Yassin et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

April-2020
Volume 43 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yassin S, Hu J, Xu H, Li C and Setrerrahmane S: [Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice. Oncol Rep 43: 1349-1349, 2020
APA
Yassin, S., Hu, J., Xu, H., Li, C., & Setrerrahmane, S. (2020). [Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice. Oncology Reports, 43, 1349-1349. https://doi.org/10.3892/or.2020.7503
MLA
Yassin, S., Hu, J., Xu, H., Li, C., Setrerrahmane, S."[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice". Oncology Reports 43.4 (2020): 1349-1349.
Chicago
Yassin, S., Hu, J., Xu, H., Li, C., Setrerrahmane, S."[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice". Oncology Reports 43, no. 4 (2020): 1349-1349. https://doi.org/10.3892/or.2020.7503